RU95106799A - Diagnosticum for rheumatic factor assay
- Google Patents
Diagnosticum for rheumatic factor assay
Info
Publication number
RU95106799A
RU95106799ARU95106799/14ARU95106799ARU95106799ARU 95106799 ARU95106799 ARU 95106799ARU 95106799/14 ARU95106799/14 ARU 95106799/14ARU 95106799 ARU95106799 ARU 95106799ARU 95106799 ARU95106799 ARU 95106799A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Г.В. Мордвинов, Md], И.В. МордвиноваfiledCriticalГ.В. Мордвинов
Priority to RU95106799/14ApriorityCriticalpatent/RU95106799A/en
Publication of RU95106799ApublicationCriticalpatent/RU95106799A/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
FIELD: medicine, rheumatology. SUBSTANCE: erythrocytes were preserved preliminary with 0.5% formalin solution, treated with bifunctional reagent, sensibilized with a mixture of hemolytic serum and human aggregated gamma-globulin and washed off with phosphate-saline buffer twice. Diagnosticum is used for rheumatic factor assay by passive hemagglutination reaction. EFFECT: enhanced sensitivity, simplified procedure.
Claims (1)
Предлагается диагностикум, предназначенный для определения ревматоидного фактора реакцией пассивной гемагглютинации. С целью увеличения сроков хранения готового диагностикума, повышения его чувствительности и упрощения последующего использования эритроциты предварительно консервируют 0,5%-ным раствором формалина, обрабатывают бифункциональным реагентом, сенсибилизируют смесью гемолитической сывороткой и агрегированного гамма-глобулина человека и дважды отмывают фосфатно-солевым буфером.A diagnosticum is proposed for determining the rheumatoid factor by the reaction of passive hemagglutination. In order to increase the shelf life of the finished diagnosticum, increase its sensitivity and simplify subsequent use, red blood cells are pre-preserved with a 0.5% formalin solution, treated with a bifunctional reagent, sensitized with a mixture of hemolytic serum and human gamma globulin and washed twice with phosphate-buffered saline.
RU95106799/14A1995-04-271995-04-27Diagnosticum for rheumatic factor assay
RU95106799A
(en)